EUVIMEDEUVIMED entdecken
Crossref

CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation

Ahmed M Awad, Sally L Elshaer, Rajashekhar Gangaraju, Rania R Abdelaziz, Manar A Nader

International Immunopharmacology · 2023-12 · 125 · 111127

DOI: 10.1016/j.intimp.2023.111127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-12. Verfasst von Ahmed M Awad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt; Department of Ophthalmology, University …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetes Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Egyptian Cultural and Educational Bureau, Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Montelukast, a cysteinyl leukotriene receptor (CysLTR)1 antagonist, is emerging as an attractive strategy to curtail diabetic complications; however, its role in aortic and testicular tissues is unknown. This study investigated the effect of CysLTR1 antagonism by montelukast on toll-like receptor (TLR)4 and nuclear factor kappa B (NF-κB) pathways in diabetes-induced aortic and testicular injury. METHODS: Adult male Sprague-Dawley rats were made diabetic with Streptozotocin (STZ, 55 mg/kg). Following this, Streptozotocin-induced diabetic (SD) rats were administered montelukast (10 and 20 mg/kg, orally) for 8 weeks. Blood glucose, serum malondialdehyde (MDA), inflammatory markers, and histopathology were evaluated. RESULTS: Montelukast showed protection against diabetic complications, as evidenced by the ameliorative effect against STZ-induced alterations in oxidative stress as indicated by serum MDA levels. Moreover, montelukast conferred a significant decrease in the aortic and testicular levels of CysLTR1, TLR4, and NF-κB with a subsequent decrease in the levels of NOD-like receptor family pyrin domain containing (NLRP)3, caspase 1, interleukin (IL)-1β, IL-6, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-α. Additionally, administration of montelukast resulted in autophagy stimulation, as shown by decreased p62/Sequestosome (SQSTM)1 levels. Finally, montelukast protection resulted in normal thickness of whole aortic wall, regular tunica (t.) intima, mild vacuolation of smooth muscle fibers in aorta, increased size of seminiferous tubules, and increased spermatogenesis in testis as demonstrated by histopathology. CONCLUSIONS: The protective effect of montelukast against diabetes-induced aortic and testicular injury is due to its antioxidant, anti-inflammatory, and autophagy stimulation characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetes ComplicationsRatsMaleAnimalsNF-kappa BRats, Sprague-DawleyStreptozocinTumor Necrosis Factor-alphaInflammationAortaAcetatesCyclopropanesQuinolinesSulfides

Stichwörter der Autor:innen

CysLTR1InflammationMontelukastNF-κBSTZTLR4

Substanzen

NF-kappa BStreptozocinTumor Necrosis Factor-alphamontelukastAcetatesCyclopropanesQuinolinesSulfides

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic…
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt.
  • Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN 38163, USA; Department of Anatomy & Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Förderung

  • Egyptian Cultural and Educational Bureau
  • Mansoura University

Zitieren

APA

Awad, A. M., Elshaer, S. L., Gangaraju, R., Abdelaziz, R. R., & Nader, M. A. (2023). CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation. International Immunopharmacology, 125, 111127. https://doi.org/10.1016/j.intimp.2023.111127

Vancouver

Awad AM, Elshaer SL, Gangaraju R, Abdelaziz RR, Nader MA. CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation. International Immunopharmacology. 2023;125:111127. doi:10.1016/j.intimp.2023.111127

BibTeX
@article{Awad2023,
  author = {Awad, Ahmed M and Elshaer, Sally L and Gangaraju, Rajashekhar and Abdelaziz, Rania R and Nader, Manar A},
  title = {CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {125},
  pages = {111127},
  doi = {10.1016/j.intimp.2023.111127}
}
Kostenlos starten →